...
首页> 外文期刊>Journal of the American College of Surgeons >Cost effectiveness of intraoperative pathology examination during diagnostic hemithyroidectomy for unilateral follicular thyroid neoplasms
【24h】

Cost effectiveness of intraoperative pathology examination during diagnostic hemithyroidectomy for unilateral follicular thyroid neoplasms

机译:诊断性甲状腺切除术中单侧滤泡性甲状腺肿瘤术中病理检查的成本效益

获取原文
获取原文并翻译 | 示例

摘要

Background: The use of intraoperative pathology examination (IPE) during diagnostic hemithyroidectomy for a follicular neoplasm is controversial. Although this service rarely alters intraoperative decision making, it does provide patients with the possibility of avoiding reoperation for completion thyroidectomy if malignancy is detected. We hypothesized diagnostic hemithyroidectomy with IPE for a unilateral follicular thyroid neoplasm diagnosed on fine-needle aspiration is not cost effective compared with diagnostic hemithyroidectomy alone. Study Design: Cost-effectiveness analysis with a Markov decision model was performed comparing diagnostic hemithyroidectomy without IPE, diagnostic hemithyroidectomy with IPE, and total thyroidectomy. Treatment outcomes and their probabilities were identified based on literature review. Costs were estimated using data from Medicare, the US Bureau of Labor Statistics, and the Nationwide Inpatient Sample. Sensitivity analysis and a 1,000-iteration Monte Carlo simulation were used to examine the uncertainty of cost, probability, and utility estimates in the model. Results: Diagnostic hemithyroidectomy without IPE had an expected cost of US$7,665 and an effectiveness of 23.95 quality-adjusted life years and dominated both the IPE and total thyroidectomy strategies. Intraoperative pathology examination became cost effective during one-way sensitivity analysis if the sensitivity of IPE increased from 14.3% to 34.4%, the specificity increased from 98.6% to 99.8%, or the pretest probability of malignancy increased from 25% to 43%. Monte Carlo simulation demonstrated that the intraoperative pathology strategy was not cost effective in 92.7% of iterations. Conclusions: Intraoperative pathology examination is not cost effective in the diagnosis of follicular thyroid neoplasms during diagnostic hemithyroidectomy. Improvements in both the sensitivity and specificity of this service would be needed to justify its use.
机译:背景:在诊断性甲状腺甲状腺切除术治疗滤泡性肿瘤期间使用术中病理检查(IPE)存在争议。尽管这项服务很少改变术中决策,但确实为患者提供了避免如果发现恶性肿瘤而再次进行甲状腺切除术的可能性。我们假设用IPE诊断半甲状腺切除术与单用诊断性甲状腺切除术相比,经细针穿刺诊断出的单侧滤泡性甲状腺肿瘤并不具有成本效益。研究设计:使用Markov决策模型进行成本效益分析,比较无IPE的诊断性甲状腺切除术,有IPE的诊断性甲状腺切除术和全甲状腺切除术。根据文献回顾确定治疗结局及其可能性。费用是根据Medicare,美国劳工统计局和全国住院患者样本的数据估算的。敏感性分析和1,000迭代的Monte Carlo模拟用于检查模型中成本,概率和效用估计的不确定性。结果:不采用IPE的诊断性甲状腺甲状腺切除术的预期成本为7,665美元,经质量调整生命年的有效期为23.95,并且在IPE和总体甲状腺切除术策略中均占主导地位。如果IPE的敏感性从14.3%增加到34.4%,特异性从98.6%增加到99.8%,或者恶性肿瘤的预检概率从25%增加到43%,则在单向敏感性分析中,术中病理检查变得具有成本效益。蒙特卡洛模拟表明,术中病理学策略在92.7%的迭代中成本效益不高。结论:术中病理学检查对诊断性甲状腺切除术中滤泡性甲状腺肿瘤的诊断成本不高。为了证明其使用的合理性,需要同时提高敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号